glp-1 analogue semaglutide Structure of semaglutide. The analog of human glucagon-like peptide-1 GLP-1 Receptor Agonists | New

Patients who maintained strict injection protocols achieved greater body weight reduction than those with variable dosing practices

In the phase 2 trial, the most reported side effects were: Nausea (affecting around 40-50% of participants at higher doses) Vomiting Diarrhoea Constipation Decreased appetite (which is also the intended effect) Most of these were mild to moderate and occurred during the dose escalation phase

A.SeveriC

They help people lose weight by: Reducing hunger Slowing stomach emptying Supporting healthier blood sugar levels Improving satiety Many patients turn to GLP-1 medications because they want a non-surgical option with medical oversight and a more straightforward path to weight loss

It should be noted, however, that oral semaglutide does require care upon administration to ensure proper absorption